PUBLISHED DATE : Jan 2020 | Pages : 263
Fill out your details & get your free sample
Cardiac Pacemaker Market Size, Share, & Trends Analysis Report by Products (MRI-conditional and Traditional), Technology (Dual-Chamber, Single Chamber, and Biventricular Pacemakers/CRT-P), Implantability (Implantable and External), End-Users (Hospitals, SSC, and ASC), and Geography (North America, Europe, APAC, Latin America, and Middle East & Africa), Industry Analysis, Price Trends, Growth Potential, Competitive Analysis & Forecast, 2020-2025
263 Pages
37 Tables
159 Charts
6 Regions
17 Countries
12 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (Revenue) | USD 5 BILLION (2025) |
| CAGR | 2% (2020-2025) |
| Base Year | 2019 |
| Forecast Year | 2020 - 2025 |
| Market Segments | Products (MRI-conditional and Traditional), Technology (Dual-Chamber, Single Chamber, and Biventricular Pacemakers/CRT-P), Implantability (Implantable and External), End-Users (Hospitals, SSC, and ASC) |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| Countries Covered | US, Canada, Germany, France, UK, Spain, Italy, Japan, China, India, South Korea, Australia, Brazil, Turkey, South Africa, Saudi Arabia, and Mexico |
The global cardiac pacemaker market size will reach USD 5 billion in 2025, growing at a CAGR of 2% during the forecast period. The growing prevalence of abnormal cardiac rhythm disorders, coupled with the increasing elderly population, which is prone to arrhythmias, is expected to drive the market. Advancements in technology and engineering provide clinicians innovative ways to care for the aging population. Cardiac pacing, particularly, has witnessed a series of game-changing technologies in the past several years spurred by low-power electronics, high-density batteries, and innovative software designs. Such innovations are expected to drive the market.
Several government bodies and private organizations are involved in spreading awareness, information, and support for cardiovascular diseases, thereby affecting the market positively. The growing patient population with arrhythmias globally requires advanced and cost-effective treatment options with minimal side-effects and complications.
This research report includes detailed segmentation by
The MRI-conditional segment accounted for over 50% of the cardiac pacemaker market share in 2019 and is expected to grow at a faster rate in the near future as several pieces of research have confirmed that over 70% of patients implanted require MRI scan during their lifespan. Many public organizations recommend implanting MRI-conditional ones to minimize the risk associated with MRI scans. Moreover, many public and private insurance companies offer reimbursement coverage for MRI scans for patients implanted with MRI-conditional devices, which increase affordability, thereby driving the market. Advancements in technology are influencing the market positively as traditional pacemakers are expected to malfunction, thus leading to complications. Hence, the increased complications related to conventional devices are likely to decrease the share of this equipment.
Dual-chamber technology is accounted for the major market share. This type of technology is likely to continue its dominance due to the increasing number of patients with abnormal heart rhythm defects. These models are highly efficient in treating cardiac arrhythmias. Besides, the number of vendors offering such pacemakers is growing as many patients prefer this type.
Single chamber devices help to minimize the risk of infections related to MRI scans and are cost-effective. The demand for single chamber ones is increasing in developing and low-income countries.
Biventricular pacemakers/CRT-P is growing at a rapid pace as these devices minimize failure chances and efficiently treat rhythm disorders. All these advantages, along with increased public and private reimbursement coverage, are expected to boost the segment.
Implantable CPs are growing at a rapid pace due to the increase in the geriatric population and the rise in arrhythmia and abnormal cardiovascular disorder prevalence rates. Advancements in technology, including the introduction of leadless, MRI-compatible, and other remote monitoring pacemaker devices, have fueled the demand for implantable ones, and the segment is expected to contribute significantly to the market. External CPs are expected to grow at a steady pace due to the increased number of patients opting for temporary cardiac devices.
Hospitals are the major end-user segment as a significant number of patients prefer to undergo surgeries in these settings due to better reimbursement policies. The growing aging population and the increasing prevalence of abnormal cardiovascular disorders are the other major factors contributing to the increase in implantation in hospitals.
Specialty cardiology centers (SCCs) are expected to grow at a significant rate owing to the availability of sophisticated infrastructure and the availability of advanced technology cardiac pacemakers these centers. Besides, SCCs have a high presence of highly skilled cardiovascular surgeons.
Ambulatory surgery centers (ASCs) are cost-effective clinics and offer high-quality care with minimal indirect treatment costs. These centers are equipped with advanced diagnostic and treatment equipment without complex administrative procedures. Such factors are likely to boost the prospects of the market.
North America accounts for a major share in the global cardiac pacemaker market. It is expected to grow at a steady rate on account of the growing volume of surgeries for treating several abnormal heart rhythms and the availability of advanced healthcare infrastructure and constant technological innovations. Europe is likely to grow at a healthy rate due to the accessibility of advanced healthcare services, especially for heart valve repair and replacement procedures. Also, the increasing incidence of abnormal heart rhythm, the rapid adoption of sophisticated cardiac pacemakers, and high healthcare expenditures are projected to increase the European market. Factors responsible for the growth of APAC are vendors' initiatives in spreading awareness and the rise in abnormal rhythm incidences due to change in living patterns, stress, and old age.
The global cardiac pacemaker market share is highly competitive and characterized by the presence of vendors offering a wide range of advanced and innovative CPs. The market is witnessing rapid technological advancements and significantly affected by new product launches. All the companies that primarily derive revenue from cardiac pacemakers are expected to grow at a favorable rate. Multiple product launches and diversified product portfolio is likely to fuel their growth in recent years. Going forward, R&D activities are expected to become crucial for companies to maintain revenue growth in the coming years. Global players with their huge infrastructure, marketing strategies, distribution network, and R&D support are likely to expand their footprint in the market. Thus, small and emerging vendors find it increasingly difficult to compete with them in terms of innovation, brand image, technology, and price.
Product
Technology
Implantability
End-user
Geography
The cardiac pacemaker market size to reach USD 5 billion by 2025, growing at a CAGR of 2% during the forecast period.
The growing prevalence of abnormal cardiac rhythm disorders, coupled with the increasing elderly population, which is prone to arrhythmias, is expected to drive the market.
The leading vendors in the market Medtronic, Boston Scientific, MicroPort Scientific, Abbott, and BIOTRONIK.
North America accounts for a major share in the global cardiac pacemaker market. It is expected to grow at a steady rate on account of the growing volume of surgeries for treating several abnormal heart rhythms and the availability of advanced healthcare infrastructure and constant technological innovations.
The MRI-conditional segment accounted for over 50% of the cardiac pacemaker market share in 2019 and is expected to grow at a faster rate in the near future as several pieces of research have confirmed that over 70% of patients implanted require MRI scan during their lifespan.
The cardiac pacemaker market is expected to grow at a CAGR of over 2% during the period 2019–2025.
The following factors are likely to contribute to the growth of the cardiac pacemaker market during the forecast period:
Base Year: 2019
Forecast Year: 2019–2025
The study considers the present scenario of the cardiac pacemaker market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent companies operating in the market.
Key Vendors
Other Vendors
Market Segmentation by Product
Market Segmentation by Technology
Market Segmentation by Implantability
Market Segmentation by End-user
Market Segmentation by Geography
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of the study
4.4 Market Segments
4.4.1 Market Segmentation by Product
4.4.2 Market Segmentation by Technology
4.4.3 Market Segmentation by Implantability
4.4.4 Market Segmentation by End-user
4.4.5 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Background
7.2 Permanent Pacemaker
7.2.1 Indications
7.3 Temporary Pacemaker
7.3.1 Indications
7.4 Cardiac Pacemaker Market Snapshot
8 Market Dynamics
8.1 Market Growth Enablers
8.1.1 High Demand for MRI-conditional Cardiac Pacemakers
8.1.2 Technological Advancements & Increasing Focus on Product Innovations
8.1.3 New Pacemaker Approvals/Launches
8.1.4 Increase in Target Patient Population with Cardiac Arrhythmias
8.2 Market Growth Restraints
8.2.1 Risks and Complications Associated with Pacemakers
8.2.2 Stringent Government Regulations & Product Recalls
8.2.3 High Cost of Pacemaker Implantation
8.3 Market Opportunities and Trends
8.3.1 Advent of Leadless Cardiac Pacemakers
8.3.2 High Growth Potential in Emerging Markets
8.3.3 Promising Investigational Pacemakers
8.3.4 Growing Demand for Automated Pacemakers Integrated with Remote Monitoring Platforms
9 Global Cardiac Pacemaker Market
9.1 Market Overview
9.2 Market Size & Forecast
9.3 Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry
10 Cardiac Pacemaker Market by Products
10.1 Market Snapshot & Growth Engine
10.2 Market Overview
10.3 MRI-conditional Cardiac Pacemakers
10.3.1 Market Overview
10.3.2 Market Size & Forecast
10.4 Traditional Cardiac Pacemakers
10.4.1 Market Overview
10.4.2 Market Size & Forecast
11 Cardiac Pacemaker Market by Technology
11.1 Market Snapshot & Growth Engine
11.2 Market Overview
11.3 Dual Chamber Pacemakers
11.3.1 Market Overview
11.3.2 Market Size & Forecast
11.4 Single Chamber Pacemakers
11.4.1 Market Overview
11.4.2 Market Size & Forecast
11.5 Biventricular Pacemakers/CRT-P
11.5.1 Market Overview
11.5.2 Market Size & Forecast
12 Cardiac Pacemaker Market by Implantability
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Implantable Pacemakers
12.3.1 Market Size & Forecast
12.4 External Pacemakers
12.4.1 Market Size & Forecast
13 Cardiac Pacemaker Market by End-User
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Hospitals
13.3.1 Market Size & Forecast
13.4 Specialty Cardiac Centers
13.4.1 Market Size & Forecast
13.5 ASCs
13.5.1 Market Size & Forecast
14 Cardiac Pacemaker Market by Geography
14.1 Market Snapshot & Growth Engine
14.2 Overview
15 North America
15.1 Market Overview
15.2 Market Size & Forecast
15.3 Key Countries
15.3.1 US: Market Size & Forecast
15.3.2 Canada: Market Size & Forecast
16 Europe
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Key Countries
16.3.1 Germany: Market Size & Forecast
16.3.2 France: Market Size & Forecast
16.3.3 UK: Market Size & Forecast
16.3.4 Spain: Market Size & Forecast
16.3.5 Italy: Market Size & Forecast
17 APAC
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 Japan: Market Size & Forecast
17.3.2 China: Market Size & Forecast
17.3.3 India: Market Size & Forecast
17.3.4 Australia: Market Size & Forecast
18 Latin America
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 Brazil: Market Size & Forecast
18.3.2 Mexico: Market Size & Forecast
19 Middle East & Africa
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Key Countries
19.3.1 Turkey: Market Size & Forecast
19.3.2 Saudi Arabia: Market Size & Forecast
19.3.3 South Africa: Market Size & Forecast
20 Competitive Landscape
20.1 Competition Overview
20.2 Market Share Analysis
20.2.1 Medtronic
20.2.2 Abbott
20.2.3 Boston Scientific
20.2.4 BIOTRONIK
20.2.5 MicroPort Scientific
21 Key Company Profiles
21.1 Medtronic
21.1.1 Business Overview
21.1.2 Major Product Offerings
21.1.3 Key Strengths
21.1.4 Key Strategies
21.1.5 Key Opportunities
21.2 Abbott
21.2.1 Business Overview
21.2.2 Major Product Offerings
21.2.3 Key Strengths
21.2.4 Key Strategies
21.2.5 Key Opportunities
21.3 Boston Scientific
21.3.1 Business Overview
21.3.2 Major Product Offerings
21.3.3 Key Strengths
21.3.4 Key Strategies
21.3.5 Key Opportunities
21.4 BIOTRONIK
21.4.1 Business Overview
21.4.2 Major Product Offerings
21.4.3 Key Strengths
21.4.4 Key Strategies
21.4.5 Key Opportunities
21.5 MicroPort Scientific
21.5.1 Business Overview
21.5.2 Major Product Offerings
21.5.3 Key Strengths
21.5.4 Key Strategies
21.5.5 Key Opportunities
22 Other Prominent Vendors
22.1 Galix Biomedical Instrumentation
22.1.1 Business Overview
22.1.2 Product Offerings
22.1.3 Key Strengths
22.1.4 Key Strategies
22.1.5 Key Opportunities
22.2 Lepu Medical
22.2.1 Business Overview
22.2.2 Product Offerings
22.2.3 Key Strengths
22.2.4 Key Strategies
22.2.5 Key Opportunities
22.3 MEDICO
22.3.1 Business Overview
22.3.2 Product Offerings
22.3.3 Key Strengths
22.3.4 Key Strategies
22.3.5 Key Opportunities
22.4 OSCOR
22.4.1 Business Overview
22.4.2 Product Offerings
22.4.3 Key Strengths
22.4.4 Key Strategies
22.4.5 Key Opportunities
22.5 Osypka Medical
22.5.1 Business Overview
22.5.2 Product Offerings
22.5.3 Key Strengths
22.5.4 Key Strategies
22.5.5 Key Opportunities
22.6 Shree Pacetronix
22.6.1 Business Overview
22.6.2 Product Offerings
22.6.3 Key Strengths
22.6.4 Key Strategies
22.6.5 Key Opportunities
22.7 Vitatron
22.7.1 Business Overview
22.7.2 Major Product Offerings
22.7.3 Key Strengths
22.7.4 Key Strategies
22.7.5 Key Opportunities
23 Report Summary
23.1 Key Takeaways
23.2 Strategic Recommendations
23.3 Quantitative Summary
23.3.1 By Product
23.3.2 By Technology
23.3.3 By Implantability
23.3.4 By End-user
23.3.5 By Geography
24 Appendix
24.1 Abbreviations
List of Exhibits
Exhibit 1 Segmentation of Global Cardiac Pacemaker Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 History of Cardiac Pacing from 1950 to 2016
Exhibit 4 Permanent Pacemaker Implantation Indications
Exhibit 5 Temporary Pacemaker Implantation Indications
Exhibit 6 Major Market Dynamics for Global Cardiac Pacemaker Market
Exhibit 7 Global Cardiac Pacemaker Share by Geography 2019 (%)
Exhibit 8 Global Cardiac Pacemaker Market by Products
Exhibit 9 Global Cardiac Pacemaker Market Share (%) in 2019
Exhibit 10 Impact of High Demand for MRI-conditional Pacemakers
Exhibit 11 Impact of Technological Advancements & Increasing Focus on Product Innovations
Exhibit 12 Advancements in Pacemaker Technology from 1950 to 2016
Exhibit 13 Evolution of Battery Usage in Cardiac Pacemaker from 1950 to 1970
Exhibit 14 Evolution of Pacemakers (Size & Weight) 1950–2013
Exhibit 15 Impact of New Pacemaker Approvals/Launches
Exhibit 16 Impact of Increase in the Target Patient Population with Cardiac arrhythmias
Exhibit 17 Age-Adjusted Prevalence of Atrial Fibrillation Among Men & Women in Developing & Developed Countries (Per 100,000 population)
Exhibit 18 Mortality Rate of Atrial Fibrillation Among Men in Developing & Developed Countries 1990-2015 (Per 100,000 population)
Exhibit 19 Mortality Rate of Atrial Fibrillation Among Women in Developing & Developed Countries 1990-2015 (Per 100,000 population)
Exhibit 20 Prevalence Rate of Atrial Fibrillation in Different Age Groups
Exhibit 21 Impact of Risks & Complications Associated with Pacemakers
Exhibit 22 Most Common Complications
Exhibit 23 Comparison of Major & Minor Complications Post Cardiac Pacemaker Implantation Up to 6 Months Follow-up
Exhibit 24 Major & Minor Complications Associated with Implantations
Exhibit 25 Major and Minor Complication Risks Percentage in Different Age Group Patients
Exhibit 26 Impact of Stringent Government Regulations Product Recalls
Exhibit 27 Devices Subjected to Class I and II Recalls as a Percentage of Estimated Worldwide Pacing System Sales 1980-1986
Exhibit 28 Impact of High Cost of Pacemaker Implantation
Exhibit 29 Percentage Breakdown of Various Cost Components in Pacemaker Implantation
Exhibit 30 Impact of Advent of Leadless Cardiac Pacemakers
Exhibit 31 Impact of High Growth Potential in Emerging Markets
Exhibit 32 Impact of Promising Investigational Pacemakers
Exhibit 33 Impact of Growing Demand for Automated Pacemakers Integrated with Remote Monitoring Platforms
Exhibit 34 Factors to be considered for Rhythmic Management (RM) Systems
Exhibit 35 Global Cardiac Pacemaker Market 2019−2025 ($ million)
Exhibit 36 Global Cardiac Pacemaker Market by Geography
Exhibit 37 Global Cardiac Pacemaker Market by Product
Exhibit 38 Global Cardiac Pacemaker Market by Technology
Exhibit 39 Global Cardiac Pacemaker Market by Implantability
Exhibit 40 Global Cardiac Pacemaker Market by End-user
Exhibit 41 Five Force Analysis 2019
Exhibit 42 Incremental Growth by Products 2019-2025
Exhibit 43 Market by Product
Exhibit 44 Market by Product: Incremental Growth
Exhibit 45 Market by Product: Absolute Growth
Exhibit 46 Market by Product 2019−2025 ($ million)
Exhibit 47 Market by Product 2019−2025 (%)
Exhibit 48 Global MRI-conditional Cardiac Pacemaker Market: Incremental $ Absolute Growth
Exhibit 49 Global Market by 2019−2025 ($ million)
Exhibit 50 Global Traditional Cardiac Pacemaker Market: Incremental $ Absolute Growth
Exhibit 51 Global Market 2019−2025 ($ million)
Exhibit 52 Incremental Growth by Technology 2019-2025
Exhibit 53 Market by Technology
Exhibit 54 Market by Technology: Incremental Growth
Exhibit 55 Market by Technology: Absolute Growth
Exhibit 56 Market by Technology 2019−2025 ($ million)
Exhibit 57 Market by Technology 2019−2025 (%)
Exhibit 58 Global Dual Chamber Pacemaker Market: Incremental $ Absolute Growth
Exhibit 59 Global Market 2019−2025 ($ million)
Exhibit 60 Global Single Chamber Pacemaker Market: Incremental $ Absolute Growth
Exhibit 61 Global Market 2019−2025 ($ million)
Exhibit 62 Global Biventricular Pacemaker Market: Incremental $ Absolute Growth
Exhibit 63 Global Market 2019−2025 ($ million)
Exhibit 64 Incremental Growth by Implantability 2019-2025
Exhibit 65 Market by Implantability
Exhibit 66 Market by Implantability: Incremental Growth
Exhibit 67 Market by Implantability: Absolute Growth
Exhibit 68 Market by Implantability 2019−2025 ($ million)
Exhibit 69 Market by Implantability 2019−2025 (%)
Exhibit 70 Global Implantable Pacemakers Market: Incremental & Absolute Growth
Exhibit 71 Global Market 2019−2025 ($ million)
Exhibit 72 Global External Pacemaker Market: Incremental & Absolute Growth
Exhibit 73 Global Market 2019−2025 ($ million)
Exhibit 74 Incremental Growth by End-user 2019-2025
Exhibit 75 Market by End-user
Exhibit 76 Market by End-user: Incremental Growth
Exhibit 77 Market by End-user: Absolute Growth
Exhibit 78 Market by End-user 2019−2025 ($ million)
Exhibit 79 Market by End-user 2019−2025 (%)
Exhibit 80 Market by Hospitals: Incremental & Absolute Growth
Exhibit 81 Market by Hospitals 2019−2025 ($ million)
Exhibit 82 Market by Speciality Cardiac Centers: Incremental & Absolute Growth
Exhibit 83 Market by Speciality Cardiac Centers 2019−2025 ($ million)
Exhibit 84 Market by ASCs: Incremental & Absolute Growth
Exhibit 85 Market by ASCs 2019−2025 ($ million)
Exhibit 86 Incremental Growth by Geography 2019-2025
Exhibit 87 Global Cardiac Pacemaker Market by Geography
Exhibit 88 Global Cardiac Pacemaker Market: Absolute Growth & Market Share
Exhibit 89 Market by Geography 2019: Key Countries ($ million)
Exhibit 90 Market by Geography: Incremental Growth
Exhibit 91 Market by Geography: Absolute Growth
Exhibit 92 Market by Geography 2019−2025 ($ million)
Exhibit 93 Market by Geography 2019−2025 (%)
Exhibit 94 North America Cardiac Pacemaker Market 2019
Exhibit 95 North America Market: Absolute & Incremental Growth
Exhibit 96 Market in North America 2019–2025 ($ million)
Exhibit 97 Incremental Growth in North America 2019-2025
Exhibit 98 Market in US 2019–2025 ($ million)
Exhibit 99 Market in Canada 2019–2025 ($ million)
Exhibit 100 Country-wise Pacemakers Implantations per Million Inhabitants 2009 vs. 2013
Exhibit 101 Europe Cardiac Pacemaker Market 2019
Exhibit 102 Europe Market: Incremental & Absolute Growth
Exhibit 103 Market in Europe 2019–2025 ($ million)
Exhibit 104 Incremental Growth in Europe 2019-2025
Exhibit 105 Number of Pacemakers Implanting Centers in EU 2013
Exhibit 106 Market in Germany 2019–2025 ($ million)
Exhibit 107 Market in France 2019–2025 ($ million)
Exhibit 108 Pacemakers Implantation Centers in UK 2012 & 2013
Exhibit 109 Market in UK 2019–2025 ($ million)
Exhibit 110 Distribution of Insurance Modality in Spain (%)
Exhibit 111 Market in Spain 2019–2025 ($ million)
Exhibit 112 Market in Italy 2019–2025 ($ million)
Exhibit 113 APAC Cardiac Pacemaker Market in 2019
Exhibit 114 APAC Market: Incremental & Absolute Growth
Exhibit 115 Payment by Governments for Cardiac Pacemakers Implantation in Various APAC Countries (%)
Exhibit 116 Market in APAC 2019–2025 ($ million)
Exhibit 117 Incremental Growth in APAC 2019-2025
Exhibit 118 Market in Japan 2019–2025 ($ million)
Exhibit 119 Market in China 2019–2025 ($ million)
Exhibit 120 Cost Comparison of Cardiac Pacemakers in India & US
Exhibit 121 Market in India 2019–2025 ($ million)
Exhibit 122 Market in Australia 2019–2025 ($ million)
Exhibit 123 Latin America Cardiac Pacemaker Market 2019
Exhibit 124 Latin America Market: Incremental & Absolute Growth
Exhibit 125 Market in Latin America 2019–2025 ($ million)
Exhibit 126 Incremental Growth in Latin America 2019-2025
Exhibit 127 Number of Implantations Performed in Various Developing Countries Per Million Population
Exhibit 128 Reimbursement Cost in Brazil ($US)
Exhibit 129 Market in Brazil 2019–2025 ($ million)
Exhibit 130 Market in Mexico 2019–2025 ($ million)
Exhibit 131 MEA Cardiac Pacemaker Market in 2019
Exhibit 132 MEA Market: Incremental & Absolute Growth
Exhibit 133 Sub-Saharan Africa Increasing Cardiac Pacing (%) 2004-2015
Exhibit 134 Market in MEA 2019–2025 ($ million)
Exhibit 135 Incremental Growth in MEA 2019-2025
Exhibit 136 Market in Turkey 2019–2025 ($ million)
Exhibit 137 Market in Saudi Arabia 2019–2025 ($ million)
Exhibit 138 Market in South Africa 2019–2025 ($ million)
Exhibit 139 Global Cardiac Pacemaker Market: Vendors Shares 2019
Exhibit 140 Medtronic Sales Revenue 2017-2019 ($ million)
Exhibit 141 Medtronic Sales Revenue by Business Segment 2018-2019 ($ million)
Exhibit 142 Medtronic Revenue Share by Business Segments 2019 (%)
Exhibit 143 Medtronic Revenue Share by Region (%) 2019
Exhibit 144 Medtronic R&D Expenditure 2017-2019 ($ million)
Exhibit 145 Abbott Sales Revenue 2016-2018 ($ billion)
Exhibit 146 Abbott Sales Revenue by Business Segment 2017 & 2018 ($ billion)
Exhibit 147 Abbott R&D Expenditure 2017 & 2018 ($ million)
Exhibit 148 Abbott Revenue Share by Business Segments 2018 (%)
Exhibit 149 Abbott Revenue Share by Countries 2018 (%)
Exhibit 150 Boston Scientific Sales Revenue 2016-2018 ($million)
Exhibit 151 Boston Scientific Sales Revenue by Business Segments 2017 & 2018 ($ million)
Exhibit 152 Boston Scientific Revenue Share Business Segments 2018 (%)
Exhibit 153 Boston Scientific Revenue Share by Region 2018 (%)
Exhibit 154 Boston Scientific R&D Expenditure 2016-2018 ($ million)
Exhibit 155 MicroPort Scientific Sales Revenue 2016-2018 ($ million)
Exhibit 156 MicroPort Scientific Sales Revenue by Business Segment 2017 & 2018 ($ million)
Exhibit 157 MicroPort Scientific Revenue Share by Business Segments 2018 (%)
Exhibit 158 MicroPort Scientific Revenue Share by Region 2018 (%)
Exhibit 159 MicroPort Scientific R&D Expenditure 2017 & 2018 ($ million)
List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2014−2019
Table 3 Major Modifications Introduced in MRI-conditional Cardiac Pacemakers
Table 4 List of MRI-Compatible Pacemakers Offered by Various Vendors
Table 5 Life Span of Few Popular Cardiac Pacemakers
Table 6 List of New Product Launch from 2014-2019
Table 7 Incidence Rate of Various Complications Post Cardiac Pacemaker Implantation
Table 8 Comparison of Micra and Nanostim Leadless Cardiac Pacemakers
Table 9 Absolute Growth Comparison of Pacemakers Between Developed and Emerging Economies (%)
Table 10 Promising Investigational Pacemaker Devices
Table 11 Vendors Offering MRI-conditional Pacemakers
Table 12 Major Vendors Offering Implantable Pacemaker
Table 13 Major Vendors Offering External pacemaker
Table 14 Provincial Reimbursement Policy in China
Table 15 Global Cardiac Pacemakers Vendor Ranking 2019
Table 16 Medtronic: Product Offerings
Table 17 Abbott: Product Offerings
Table 18 Boston Scientific: Product Offerings
Table 19 BIOTRONIK: Product Offerings
Table 20 MicroPort Scientific: Product Offerings
Table 21 Galix Biomedical Instrumentation: Key Product Offerings
Table 22 Lepu Medical: Key Product Offerings
Table 23 MEDICO: Key Product Offerings
Table 24 OSCOR: Key Product Offerings
Table 25 Osypka Medical: Key Product Offerings
Table 26 Shree Pacetronix: Key Product Offerings
Table 27 Vitatron: Product Offerings
Table 28 Market by Product ($ million)
Table 29 Market by Product (%)
Table 30 Market by Technology ($ million)
Table 31 Market by Technology (%)
Table 32 Market by Implantability ($ million)
Table 33 Market by Implantability (%)
Table 34 Market by End-user ($ million)
Table 35 Market by End-user (%)
Table 36 Market by Geography ($ million)
Table 37 Market by Geography (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
